Title |
Identification of study as randomised |
Identification of study as a within person trial (or an alternative accepted term in the specialty) |
Trial design |
Description of the trial design (eg parallel, cluster, non-inferiority) |
|
Methods: |
|
|
Participants |
Eligibility criteria for participants and the settings where the data were collected |
Eligibility criteria for body sites |
Interventions |
Interventions intended for each group |
Intervention timing: sequential or concurrent |
Objective |
Specific objective or hypothesis |
|
Outcome |
Clearly defined primary outcome for this report |
|
Randomisation |
How participants were allocated to interventions |
How body sites were allocated within a single participant |
Blinding(masking) |
Whether or not participants, care givers, and those assessing the outcomes were blinded to group assignment |
|
Results: |
|
|
Numbers randomised |
Number of participants randomised to each group |
Number of body sites randomised to each group |
Recruitment |
Trial status |
|
Numbers analysed |
Number of participants analysed in each group |
Number of body sites analysed in each group |
Outcome |
For the primary outcome, a result for each group and the estimated effect size and its precision |
|
Harms |
Important adverse events or side effects |
For participants and for body sites |
Conclusions |
General interpretation of the results |
|
Trial registration |
Registration number and name of trial register |
|
Funding |
Source of funding |
|